Delivery Order SPE2DB20D9214-SPE2DB24FD4UX

Award Date 7/3/24
Potential Completion Date 7/25/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $49,286.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Entyvio 300 mg vials, a specialized pharmaceutical product, with a performance period through December 4, 2024. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,473.84, is for the supply of Entyvio 300 mg vials, a biologic medication. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $39,429.44, is to provide Entyvio 300 mg vials to support the recurring pharmaceutical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $73,930.20 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Entyvio 300 mg vials, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA's Medical Supply Chain division, valued up to $499,999,999, which provides a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,944.93, is for the delivery of Entyvio 300 mg vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,177.37 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of 4,559,384,142 units of the medication Entyvio 300 mg vials. This contract is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which allows the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $147,860.40 contract is for the delivery of Entyvio 300 mg vials, a biologic medication, to support the recurring pharmaceutical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $34,500.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Entyvio 300 mg vials, with a period of performance through July 5, 2024. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,928.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Entyvio 300 mg vials, a specialized pharmaceutical product, with a period of performance through January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $24,724.65, is for the delivery of Entyvio 300 mg vials, a pharmaceutical product, with a performance period through May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and DLA, valued at $499,999,999 and valid through...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4UX
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $29,572.08 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Entyvio 300 mg vials, a biologic medication used to treat certain inflammatory bowel diseases. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 10/2/24, 11:37 AM